News PeptiDream Inc.

Equities

4587

JP3836750004

Market Closed - Japan Exchange Other stock markets 07:00:00 05/07/2024 BST			5-day change	1st Jan Change
2,510 ^JPY	+0.64%		+0.76%	+68.85%

06-14	PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	MT
06-04	National Cancer Center and PeptiDream Announces the First Dosing of Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

PeptiDream : Corporate Overview（July 2024, English version)	07-01	PU
PeptiDream and Novartis Agreement Becomes Effective with 28.3 Billion Yen Upfront Payment	06-14	MT
NCC and PeptiDream Announce the First Dosing of 64Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma	06-04	BU
National Cancer Center and PeptiDream Announces the First Dosing of Cu-PD-32766 in a patient with Clear Cell Renal Cell Carcinoma	06-04	CI
Peptidream Inc. Revises Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	05-14	CI
Jefferies Adjusts PeptiDream’s Price Target to 1,900 Yen From 1,400 Yen, Keeps at Hold	05-07	MT
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis	04-30	BU
Peptidream Announces Expansion of Peptide Discovery Collaboration with Novartis	04-30	CI
PeptiDream Inc. Announces Expansion of Peptide Discovery Collaboration with Novartis Pharma AG	04-30	CI
Certain Preferred Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Stock Options of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
Certain Common Stock of RayzeBio, Inc. are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
PeptiDream to Partake in Bristol Myers' Tender Offer for All RayzeBio Shares	02-15	MT
PeptiDream Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2024	02-14	CI
PeptiDream Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-14	CI
Jefferies Adjusts PeptiDream's Price Target to 1,400 Yen From 1,300 Yen, Keeps at Hold	01-24	MT
Linqmed Inc. announced that it has received ¥680 million in funding from a group of investors	12-21	CI
PeptiDream Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-09	CI
PeptiDream : Corporate Presentation（November 2023, English version)(2MB)	11-01	PU
PeptiDream : コーポレート・プレゼンテーション(2023年11月、英語版）(2MB)	11-01	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PeptiDream Inc.

Equities

4587

JP3836750004

Summary

Filters